Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
BFS Saul Centers posts 45 percent Q3 2025 EPS miss with shares dipping 041 percent despite 78 percent revenue growth Global GMM Stock Emerging Market Bond 074 20260424 FPH Five Point reports 538 YoY Q4 2025 revenue drop shares edge 019 lower following earnings release Market Recap Tech leads gains as consumer lags amid mild market pullback Vertex Pharmaceuticals VRTX Positioned to Capture Material Share in the FastGrowing IgA Nephropathy Market Via Lead LateStage Asset Povetacicept TBHC The Brand posts 424 percent negative EPS surprise in Q1 2026 as share price remains unchanged CNET ZW Data Tech gains over five percent even as Q3 2011 earnings fall far short of analyst expectations O Realty posts a nearly 20 percent Q4 2025 EPS miss pushing shares down 117 percent today Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Caseys General Stores Identified as Jim Cramers Hidden Gem Ferrari Launches First AllElectric Model FourDoor Luce Priced at 640000 Energy Transfer ET Receives Higher Price Target Amid Improved EBITDA Forecast Consumer Sentiment Falls to Record Low in May Amid Iran Conflict and Inflation Fears Nio Shares Surge on Launch of First Flagship SUV in Over Two Years TCBX Q1 2026 Earnings EPS Surpasses Estimates as Bank Delivers Solid BottomLine Performance PRHIZ Q1 2024 Earnings Strong EPS Surprise Revenue Not Disclosed DTG Q1 2026 Earnings EPS Miss Raises Caution on Utility Performance AERT Q1 2026 Earnings Profitability Achieved Despite Limited Disclosure RCMT Q1 2026 Earnings EPS Misses Analyst Expectations as Stock Rebounds GWW Q1 2026 Earnings EPS Exceeds Estimates by Nearly 13 Despite Slight Stock Decline SiNtx Technologies SINT Attempts Recovery Faces Key Test at 247 Resistance RiverNorth Capital and Income Fund RSF Consolidates Near 1459 as Market Awaits Catalyst Ernexa Therapeutics Warrants ERNAW Slide Marginally to 015 Testing Key Support Zone Palisade Bio Inc PALI Edges Higher on Modest Volume Testing Resistance Levels SelectQuote Inc SLQT Slides 566 to 10 as Sellers Test Support Near 095